Published in IARC Sci Publ on January 01, 1999
Stereospecific formation of interstrand carbinolamine DNA cross-links by crotonaldehyde- and acetaldehyde-derived alpha-CH3-gamma-OH-1,N2-propano-2'-deoxyguanosine adducts in the 5'-CpG-3' sequence. Chem Res Toxicol (2006) 1.11
Polyamines stimulate the formation of mutagenic 1,N2-propanodeoxyguanosine adducts from acetaldehyde. Nucleic Acids Res (2005) 1.04
Stereochemistry modulates the stability of reduced interstrand cross-links arising from R- and S-alpha-CH3-gamma-OH-1,N2-propano-2'-deoxyguanosine in the 5'-CpG-3' DNA sequence. Biochemistry (2007) 0.90
Induction of heme oxygenase-1 inhibits cell death in crotonaldehyde-stimulated HepG2 cells via the PKC-δ-p38-Nrf2 pathway. PLoS One (2012) 0.89
Role of lipid peroxidation-derived α, β-unsaturated aldehydes in vascular dysfunction. Oxid Med Cell Longev (2013) 0.80
SIOP Working Committee on Psychosocial issues in pediatric oncology: guidelines for care of long-term survivors. Med Pediatr Oncol (1996) 1.42
Polymorphic DNA haplotypes at the phenylalanine hydroxylase (PAH) locus in European families with phenylketonuria (PKU). Am J Hum Genet (1989) 1.41
Heterogeneous spectrum of mutations in the Fanconi anaemia group A gene. Eur J Hum Genet (1999) 1.36
Familial occurrence of congenital malformations and ring chromosome (46,XX,Cr). J Med Genet (1970) 1.19
The adverse effect of prolonged prednisolone pretreatment in children with acute lymphoblastic leukemia. Cancer (1985) 1.18
Carcinogenicity study of trichloroethylene by longterm inhalation in three animal species. Arch Toxicol (1980) 1.08
Human recombinant granulocyte-macrophage colony-stimulating factor in pediatric oncology practice. Pediatr Hematol Oncol (1994) 1.08
Childhood leukaemia in Europe after Chernobyl: 5 year follow-up. Br J Cancer (1996) 1.04
Morphological diagnosis in childhood leukaemia. Br J Haematol (1978) 1.01
Carcinogenicity of trichloroethylene: fact or artifact? Arch Toxicol (1977) 1.00
Christmas disease in one of a pair of monozygotic twin girls, possibly the effect of lyonization. J Med Genet (1972) 0.96
Mutagenic properties of allylic and alpha, beta-unsaturated compounds: consideration of alkylating mechanisms. Xenobiotica (1982) 0.95
[Current methods for study of human chromosomes]. Orv Hetil (1965) 0.94
The pathological response and fate in the lung and pleura of chrysotile in combination with fine particles compared to amosite asbestos following short-term inhalation exposure: interim results. Inhal Toxicol (2010) 0.92
Psychosocial problems in families of a child with cancer. Med Pediatr Oncol (1985) 0.91
Detection of 1,N2-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal after gavage of trans-4-hydroxy-2-nonenal or induction of lipid peroxidation with carbon tetrachloride in F344 rats. Chem Biol Interact (2001) 0.90
Crotonaldehyde is mutagenic in Salmonella typhimurium TA100. Environ Mol Mutagen (1989) 0.90
Guidelines for a therapeutic alliance between families and staff: a report of the SIOP Working Committee on Psychosocial Issues in Pediatric Oncology. Med Pediatr Oncol (1998) 0.90
Mutagenicity of methylvinyl ketone in Salmonella typhimurium TA100--indication for epoxidation as an activation mechanism. Mutat Res (1989) 0.89
Molecular genetics of PKU in eastern Europe: a nonsense mutation associated with haplotype 4 of the phenylalanine hydroxylase gene. Somat Cell Mol Genet (1990) 0.89
Breast reconstruction by the free lower transverse rectus abdominis musculocutaneous flap. Br J Plast Surg (1988) 0.88
Hemihypertrophy: 10 years follow-up and chromosomal study. Acta Paediatr Acad Sci Hung (1965) 0.88
Development of a (32)P-postlabeling method for the detection of 1,N(2)-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal in vivo. Chem Res Toxicol (2000) 0.86
Genotoxicity and mutagenicity of the alpha, beta-unsaturated carbonyl compound crotonaldehyde (butenal) on a plasmid shuttle vector. Mutat Res (1998) 0.85
The saphenous neurovascular free flap. Plast Reconstr Surg (1981) 0.85
Crotonaldehyde is mutagenic in a modified Salmonella typhimurium mutagenicity testing system. Mutat Res (1981) 0.85
Quantification of the pathological response and fate in the lung and pleura of chrysotile in combination with fine particles compared to amosite-asbestos following short-term inhalation exposure. Inhal Toxicol (2011) 0.85
Mutagenic potential of allyl and allylic compounds. Structure-activity relationship as determined by alkylating and direct in vitro mutagenic properties. Biochem Pharmacol (1980) 0.84
Allylic compounds bind directly to DNA: investigation of the binding mechanisms in vitro. Chem Biol Interact (1987) 0.83
Thyroid autoantibodies and satellite associations in Down's syndrome. Hum Hered (1970) 0.83
Development of a 32P-postlabelling method for the detection of 1,N2-propanodeoxyguanosine adducts of crotonaldehyde in vivo. Arch Toxicol (2000) 0.83
Correlation of alkylating and mutagenic activities of allyl and allylic compounds: standard alkylation test vs. kinetic investigation. Chem Biol Interact (1982) 0.83
Psychological late effects of leukemia in children and their prevention. Med Pediatr Oncol (1981) 0.83
Coping with cadmium exposure in various ways: the two helicid snails Helix pomatia and Cantareus aspersus share the metal transcription factor-2, but differ in promoter organization and transcription of their Cd-metallothionein genes. J Exp Zool A Ecol Genet Physiol (2009) 0.83
Cancer risk assessment for the environmental mutagen and carcinogen crotonaldehyde on the basis of TD(50) and comparison with 1,N(2)-propanodeoxyguanosine adduct levels. Cancer Epidemiol Biomarkers Prev (2001) 0.83
Mutagenicity and genotoxicity of ethylvinyl ketone in bacterial tests. J Appl Toxicol (1990) 0.83
Detection of 1,N(2)-propanodeoxyguanosine adducts in DNA of Fischer 344 rats by an adapted (32)P-post-labeling technique after per os application of crotonaldehyde. Carcinogenesis (2000) 0.83
Carcinogenicity study of trichloroethylene, with and without epoxide stabilizers, in mice. J Cancer Res Clin Oncol (1984) 0.82
The role of biotransformation in the genotoxicity of allylic compounds. Arch Toxicol (1987) 0.82
Leukaemia in children with Down's syndrome. Oncology (1983) 0.81
A new pathway of acrolein metabolism in rats. Arch Toxicol (1983) 0.81
Chromosomal peculiarities and "in vitro" examinations in Fanconi's anaemia. Humangenetik (1969) 0.80
Unaltered brain levels of 1,N2-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal in Alzheimer's disease. Neurosci Lett (2002) 0.80
Detection of acrolein congener-DNA adducts isolated from cellular systems. Arch Toxicol Suppl (1989) 0.80
Phytohaemagglutinin-induced leukocyte migration inhibition and phytohaemagglutinin skin test for screening the cell-mediated immune response in children. Allergy (1980) 0.80
No clastogenic activity of a senna extract in the mouse micronucleus assay. Mutat Res (1999) 0.79
Cell-mediated immune response in patients with Down's syndrome. Acta Paediatr Acad Sci Hung (1974) 0.79
Genotoxicity of 1,3-dichloro-2-propanol in the SOS chromotest and in the Ames test. Elucidation of the genotoxic mechanism. Chem Biol Interact (1991) 0.79
[Neurologic complications of childhood malignancies]. Orv Hetil (1994) 0.79
Malignancies in patients treated with high doses of radium-224. Radiat Res (1999) 0.79
[Pituitary function and growth in children under treatment for leukemia (author's transl)]. Monatsschr Kinderheilkd (1980) 0.79
Immunological and virological investigations in Down's syndrome. Eur J Pediatr (1982) 0.79
Lymphoblastic transformation, chromosome pattern and delayed-type skin reaction in ataxia telangiectasia. Acta Paediatr Scand (1971) 0.79
Genotoxic and cell-transforming properties of (trans,trans)-muconaldehyde. Mutat Res (1991) 0.78
Induction of unscheduled DNA synthesis in HeLa cells by allylic compounds. Cancer Lett (1983) 0.78
Consumer evaluation of the quality of hospital services from an economics of information perspective. J Health Care Mark (1990) 0.78
L-asparaginase therapy and its complications in acute lymphoid leukaemia and generalized lymphosarcoma. Haematologia (Budap) (1976) 0.78
Structure-activity relationships of alpha, beta-unsaturated carbonylic compounds. IARC Sci Publ (1986) 0.77
[Prognostic significance of systemic clearance of methotrexate in acute lymphoid leukemia in childhood]. Orv Hetil (1986) 0.77
Comparative analysis of 8-oxo-2' -deoxyguanosine in DNA by 32P- and 33P-postlabeling and electrochemical detection. Carcinogenesis (1997) 0.76
The association of HLA-DR5 antigen with longer survival in childhood leukaemia. Br J Haematol (1981) 0.76
Methotrexate administered by 6-h and 24-h infusion: a pharmacokinetic comparison. Cancer Chemother Pharmacol (1988) 0.76
Recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia in children with malignant solid tumours. Eur J Cancer (1998) 0.76
Safety of dexrazoxane in children with all undergoing anthracycline therapy: preliminary results of a prospective pilot study. Pediatr Hematol Oncol (1997) 0.76
Paraneoplastic syndrome in childhood. Acta Paediatr Acad Sci Hung (1977) 0.75
Acute myeloid leukemia in childhood: 12 years experience of treatment in Hungary. Haematologia (Budap) (1985) 0.75
Causes of low birthweight in Hungary. Acta Paediatr Hung (1984) 0.75
[Congenital and hereditary nephropathies in children based on epidemiological research data]. Vestn Akad Med Nauk SSSR (1984) 0.75
Mosaicism. Acta Paediatr Acad Sci Hung (1966) 0.75
[Lymphoblastic transformation, chromosome picture and delayed skin reaction in ataxia teleangiectasia]. Orv Hetil (1969) 0.75
[Cumulative developmental anomalies and the incidence of ring-chromosome (C) in one family]. Orv Hetil (1969) 0.75
[Management of infantile Hodgkin's disease with combined chemotherapy]. Orv Hetil (1984) 0.75
Down's syndrome and malignancy. Acta Paediatr Acad Sci Hung (1972) 0.75
[Down syndrome and malignancy]. Orv Hetil (1972) 0.75
[Malignant tumors and immunity]. Orv Hetil (1971) 0.75
[Deep-freezing of boar semen: a comparison of two methods]. Schweiz Arch Tierheilkd (1979) 0.75
Leucocyte migration in presence of leukaemia-associated antigens in children with Down's syndrome. Haematologia (Budap) (1976) 0.75
Malignant tumours and immunity. Ther Hung (1972) 0.75
[Results and problems in the treatment of childhood leukaemia (author's transl)]. Monatsschr Kinderheilkd (1978) 0.75
[Further comments on visiting the hospitalized child]. Orv Hetil (1980) 0.75
Therapeutic results: report of the Hungarian children's leukaemia study group. Haematologia (Budap) (1976) 0.75
[Iatrogenic carcinogenesis]. Orv Hetil (1978) 0.75
[Paraneoplastic syndrome in childhood]. Orv Hetil (1977) 0.75
[Leukosis and heredity]. Acta Paediatr Acad Sci Hung (1972) 0.75
[Effect of previous prednisolone therapy on the survival of children with acute lymphoid leukemia]. Orv Hetil (1984) 0.75
Recent results in cancer research related to non-solid tumors in children. Osterr Z Onkol (1977) 0.75
[Chromosome studies in Fanconi's anemia]. Orv Hetil (1969) 0.75
[Mutations induced in vitro by an alkylating agent (zitostop) in malignant diseases and in syndromes predisposing to malignancy]. Humangenetik (1972) 0.75
Lymphocyte subpopulations in peripheral blood of small-for-gestational age and appropriate-for-gestational age preterm neonates. Acta Paediatr Hung (1984) 0.75
[On mosaicism]. Orv Hetil (1967) 0.75
Hemihypertrophy: incidence and chromosomal examinations. Acta Paediatr Acad Sci Hung (1968) 0.75
[Use of the recombination gene technic (gene splicing) in clinical medicine]. Orv Hetil (1985) 0.75
[Methotrexate levels in the blood and cerebrospinal fluid in children with acute lymphoid leukemia treated with medium doses of methotrexate]. Orv Hetil (1984) 0.75
[Role of cytogenetic studies in acute non-lymphoid leukemia in children]. Orv Hetil (1985) 0.75
Down's syndrome: chromosome analysis of 362 cases in Hungary. Hum Hered (1977) 0.75
[Silver-Russel type growth retardation]. Orv Hetil (1977) 0.75
Chromosome mutations and chromosome stability in children treated with different regimes of immunosuppressive drugs. Hum Hered (1979) 0.75
[Chromosome abnormality with unilateral congenital developmental anomalies]. Orv Hetil (1972) 0.75
Cross-resistance of transformed mouse cells to some drugs. Acta Biol Acad Sci Hung (1976) 0.75